Navigation Links
Cough Syrup Might Help With Dosing of Breast Cancer Drug

FRIDAY, Nov. 19 (HealthDay News) -- A new, small study suggests that the main ingredient in cough syrup might help doctors determine the best dose of tamoxifen, a drug commonly used to prevent and treat breast cancer.

The idea is that the body absorbs cough medicine at about the same rate as tamoxifen, allowing doctors to use it to test how patients respond to the breast-cancer drug.

"This study is starting to identify a personalized medicine type of approach that will help identify those patients who should have their tamoxifen doses adjusted," said Dr. Leonidas Koniaris, who's familiar with the study findings. He's an associate professor of surgery at the Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine in Florida.

Currently, it can be difficult to set a proper dose of tamoxifen for a patient. If the dose is off, the drug may lose effectiveness or cause a higher number of side effects, the study authors said.

The authors, led by Anne-Joy de Graan, a graduate student at Erasmus Medical Center in Rotterdam, the Netherlands, focused on whether dextromethorphan, the active ingredient in cough medicine, is metabolized by the body at about the same rate as tamoxifen. Dextromethorphan "is a so-called 'probe' drug, a harmless substance that can be used to predict the metabolism of another drug," de Graan said in a news release provided by the European Cancer Organization.

The study authors gave 30 milligrams of dextromethorphan in cough syrup form to 40 breast cancer patients and then gave them tamoxifen two hours later. Over the next 24 hours the researchers determined whether the women's bodies metabolized the drugs at similar rates. They did.

The cough medicine test needs more research and isn't ready to be used in doctors' offices, Koniaris stressed. The next steps will be to validate the research and see if the test results actually lead to better health for patients. For now, he said, "it certainly looks quite promising."

The study findings were to be released Friday at the Symposium on Molecular Targets and Cancer Therapeutics in Berlin, Germany. Research presented at meetings should be viewed as preliminary until it is published in a peer-reviewed journal.

More information

There's more on tamoxifen at the U.S. National Cancer Institute.

-- Randy Dotinga

SOURCES: European Cancer Organization, news release, Nov. 19, 2010; Leonidas Koniaris, M.D., an associate professor of surgery, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Cough medicine could help doctors identify how breast cancer patients metabolize tamoxifen
2. Too Few Adults Vaccinated Against Whooping Cough: CDC
3. Spread of Whooping Cough Raises Concern
4. Commentary suggests alternatives to routine use of OTC cold/cough meds in children
5. New commentary suggests alternatives to routine use of OTC cold/cough meds in children
6. TechWorld Medicals NasalCare Nasal Cleanse Kit Named “Best New Product” at ECRM Cough & Cold and Allergy Conference
7. New Simply...Go-Gurt Contains No High Fructose Corn Syrup, Artificial Flavors or Colors
8. Nerve Zap to Kidneys Might Ease Stubborn Hypertension
9. Cholesterol on Eyelids Might Point to Heart Risk
10. Special Infant Formula Might Help Shield Babies from Type 1 Diabetes
11. Diabetes Drugs Might Lower Risk of Lung Cancer
Post Your Comments:
Related Image:
Cough Syrup Might Help With Dosing of Breast Cancer Drug
(Date:11/27/2015)... ... November 27, 2015 , ... According to an article published ... that they are handling security in light of the recent terrorist attacks in Paris, ... attempt to stop an attack from reaching U.S. soil. Especially around special events that ...
(Date:11/27/2015)... ... 2015 , ... A team of Swiss doctors has released a report on ... just posted the findings on the website. Click here to read the details ... mesothelioma patients who were treated with chemotherapy followed by EPP surgery. Among the 106 ...
(Date:11/27/2015)... ... November 27, 2015 , ... "When I was traveling, I ... Hillside, N.J. "Many people catch diseases simply from sitting on such dirty toilet ... protected from germs." , He developed the patent-pending QUDRATECS to eliminate the need ...
(Date:11/27/2015)... ... November 27, 2015 , ... The print component ... Today in Atlanta, Dallas, New York, Minneapolis, South Florida, with a circulation of ... distributed nationally, through a vast social media strategy and across a network of ...
(Date:11/27/2015)... ... November 27, 2015 , ... MPWH, the No.1 Herpes-only dating community in the world, ... Table 1-1 ). More than 3.7 billion people under the age of 50 – ... according to WHO's first global estimates of HSV-1 infection . , "The data shocks ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... November 26, 2015 ... addition of the  "2016 Future Horizons ... Therapeutic Drug Monitoring (TDM) Market: Supplier ... Emerging Opportunities"  report to their offering.  ... announced the addition of the  "2016 ...
(Date:11/26/2015)... DUBLIN , November 26, 2015 ... has announced the addition of the  ... in the European Cell Surface Marker ... Emerging Opportunities"  report to their offering.  ... announced the addition of the  "2016 ...
(Date:11/25/2015)...  Linden Care, LLC, a retail specialty pharmacy focused ... suffering from chronic pain, said today that it is ... (TRO) enjoining Express Scripts from unilaterally terminating the Pharmacy ... --> --> The company said that ... --> --> In ...
Breaking Medicine Technology: